May 25, 2023
CMA letter: Canada needs a comprehensive approach to supporting older adultsAs Canadians continue to live longer, the CMA highlights its concerns with the efficacy of Bill C-295, An Act to amend the Criminal Code (neglect of vulnerable adults) in achieving its intended impacts and outlines recommendations for a more robust approach to supporting older adults in aging with dignity.
March 6, 2023
CMA submission: Recommendations on health infrastructure fundingRecognizing the critical role health facilities play in meeting the needs of communities across the country and the disruptive and devastating impact climate change continues to have on Canadians’ health, the CMA outlines four recommendations for federal investment in climate-resilient and sustainable health infrastructure.
October 6, 2022
CMA 2023 pre-budget submission: Tackling Canada’s urgent health care crisisIn this submission to the House of Commons Standing Committee on Finance, the CMA proposes recommendations to address a collapsing health care system and lay the foundation for a robust system moving forward. Recommendations include enabling pan-Canadian licensure, health human resources planning and advancing reconciliation.
June 23, 2022
CMA recommendations on Canada’s first national adaptation strategy to address climate changeRecognizing the devastating health impacts of climate change, in this submission to government the CMA outlines how the health sector and all levels of government can contribute to climate change adaption.
May 13, 2022
CMA submission: Recommendations on vaccine equity and intellectual propertyIn this submission to the House of Commons Standing Committee on Foreign Affairs and International Development, the CMA highlights Canada’s obligation to contribute to global vaccination efforts, which not only support vaccine equity but help Canada’s domestic public health response by reducing the likelihood of the emergence of vaccine-resistant variants.
May 9, 2022
Appearance before House of Commons committee to address the health human resources emergencyCMA President Dr. Katharine Smart appears before the Standing Committee on Health to highlight potential actions that would help mitigate Canada’s health human resources crisis, reduce surgical backlogs, expand access to primary care, and more.
May 3, 2022
Appearance before House of Commons committee to discuss the Non-Insured Health Benefits (NIHB) programIn his remarks before the Standing Committee on Indigenous and Northern Affairs, CMA President-Elect Dr. Alika Lafontaine explains how improving the administration of the NIHB program is a key part of addressing the health inequities between Indigenous and non-Indigenous people in Canada.
April 14, 2022
CMA submission: Recommendations to address the health human resources crisisIn this submission to the House of Commons Standing Committee on Health, the CMA and Canadian Nurses Association — in partnership with the College of Family Physicians of Canada — outline eight policy pillars critical in alleviating the health human resources crisis.
March 28, 2022
Appearance before House of Commons committee to discuss health workforce crisisCMA President Dr. Katharine Smart appears before the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities to highlight the need for strategic federal investments to support rebuilding health care delivery in Canada.
February 16, 2022
Appearance before House of Commons committee to study Canada’s health workforceCMA President Dr. Katharine Smart appears before the House of Commons Standing Committee on Health to welcome a study on Canada’s health workforce. In her remarks, she explains physician burnout is at an all-time high and the health workforce is in the midst of a crisis.
February 15, 2022
CMA 2022 pre-budget submission: Addressing Canada’s health care crisisIn this submission to the House of Commons Standing Committee on Finance, the CMA proposes recommendations to tackle Canada’s health care crisis and create a foundation for a stronger health care system in the future. Recommendations include investing in health workforce planning, increasing access to primary care and addressing surgical backlogs.
February 9, 2022
Appearance before senate committee to support Pandemic Observance DayCMA President Dr. Katharine Smart appears before the Senate Standing Committee on Social Affairs, Science and Technology to support Bill S-209, An Act Respecting Pandemic Observance Day. In her remarks, she explains it offers a chance to reflect on what we’ve collectively been through and the lessons we’ve learned.
February 2, 2022
CMA submission: Advancing pan-Canadian licensureThis document provides federal policy options to advance pan-Canadian licensure by reducing interprovincial and interterritorial barriers.
December 15, 2021
CMA Submission to the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities’ study of Bill C-3, An Act to amend the Criminal Code and the Canada Labour CodeThe CMA applauds the federal government for taking rapid action and introducing new legislation to protect health workers from threats, intimidation and violence, and urges Parliament to support its enactment.
December 10, 2021
CMA Submission to the Standing Committee on Social Affairs, Science and Technology’s study of Bill C-3, An Act to amend the Criminal Code and the Canada Labour CodeIn this letter, the CMA strongly supports the introduction of new legislation to protect health workers from threats, intimidation and violence, and urges Parliament to support its enactment.
November 17, 2021
Canadian Medical Association input in advance of the World Health Assembly Special SessionFor consideration by the Canadian delegation, this CMA letter highlights recommendations for addressing gaps in the global response to the COVID-19 pandemic, including improving equitable vaccine access and distribution.
November 9, 2021
Canada’s doctors and nurses urgently calling for federal measures to address Canada’s health workforce crisisIn this joint letter to the prime minister, the CMA and Canadian Nurses Association urge the federal government to follow through on its health commitments, including actions to improve access to primary, mental health and long-term care, eliminate health system waitlists and protect health workers from harassment.
September 28, 2021
The Canadian Medical Association (CMA) and the Fédération des médecins omnipraticiens du Québec (FMOQ) partner for medical leadership trainingThe Fédération des médecins omnipraticiens du Québec (FMOQ) and the Canadian Medical Association (CMA) announced a partnership to develop and deliver medical leadership training.
August 5, 2021
CMA 2022 Pre-Budget Submission to the House of Commons Standing Committee on FinanceThis submission proposes recommendations to reimagine Canada’s health systems as part of its COVID-19 pandemic recovery, including increasing the Canada Health Transfer, enabling access to primary care, increasing public health capacity, establishing an older adults care benefit and reducing interprovincial mobility barriers for health professionals.
June 25, 2021
Digital health care and competition – A perspective from the Canadian Medical AssociationResponding to the federal Competition Bureau’s market study on digital health care, the CMA weighs in on the challenges and opportunities in this space, including quality, interoperability, governance, privacy and security, pan-Canadian licensure and compensation.
June 24, 2021
CMA Letter - Bill C-30 ImplementationBill C-30, the 2021 Budget Implementation Act, included a key CMA recommendation to introduce additional investments to the Canada Health Transfer to support provinces and territories in rebuilding the country’s health care system after the COVID-19 pandemic.
June 23, 2021
CMA submission: The Future of Care for Canada’s Older AdultsIn this submission to a parliamentary committee, the CMA outlines recommendations to improve care for older adults, including sustained funding for health care, national standards in long-term care, supports for aging in place and a Seniors Care Benefit.
May 26, 2021
National Approach to LicensureThis joint letter to provincial and territorial health ministers makes the case for a national approach to licensure, underscoring the state of crisis of the health care system and the need to address the mobility of heath care professionals across jurisdictions to improve access to care.
May 20, 2021
Appearance before the House of Commons Standing Committee on Finance Bill C-30: The Budget Implementation Act, 2021In her remarks, CMA President Dr. Ann Collins urges the committee to include $1.2 billion of funding over four years in Budget 2021 to expand the establishment of primary care teams and enhance equitable access to care for Canadians across the country.
April 23, 2021
Appearance before the House of Commons Standing Committee on Health: Study on the Emergency Situation Facing Canadians in Light of the COVID-19 PandemicCMA President Dr. Ann Collins calls for continued collaboration between federal, provincial and territorial governments in responding to the pandemic, and for additional resources to bolster the weakened health care system, including to expand primary care.
March 3, 2021
CMA response: Health Canada consultation on the concentration of nicotine in vaping products regulationsThe CMA reiterates its support to establish a maximum nicotine concentration of 20 mg/mL for vaping products manufactured or imported for sale in Canada, and to prohibit the packaging and sale of vaping products if the nicotine concentration displayed on the package exceeds that value
January 21, 2021
Learning from the pandemic – Transforming and improving Quebec’s health care systemThis submission for the 2021–2022 Quebec government budget outlines CMA recommendations on physician wellness, access to virtual care, the care of older persons and Indigenous peoples, and the health impacts of climate change.
November 30, 2020
Committee Appearance: House of Commons Standing Committee on Health (HESA)CMA President Dr. Ann Collins calls on government and health authorities to protect Canadians and care providers during the COVID-19 pandemic, including by enhancing access to mental health resources, addressing backlogs in medical services, expanding primary care teams and boosting public health capacity.
November 23, 2020
Committee Appearance – Senate Legal and Constitutional Affairs Committee: Bill C-7 – An Act to Amend the Criminal Code (medical assistance in dying)CMA Past President Dr. Sandy Buchman provides input on this legislation to committee, including around the importance of using non-stigmatizing language, introducing safeguards to protect patient rights, and expanding data collection on medical assistance in dying.
November 5, 2020
Committee Appearance – Justice and Human Rights: Bill C-7 – Amending the Criminal Code Regarding Medical Assistance in DyingIn her remarks, CMA President Dr. Ann Collins provides input on this legislation to committee, including around the importance of using non-stigmatizing language, introducing safeguards to protect patient rights, and expanding data collection on medical assistance in dying.
September 29, 2020
CMA submission: Valuing caregivers and recognizing their contribution to Quebec’s health systemIn this submission to the National Assembly review of Bill 56, on the role of caregivers in Quebec, the CMA makes several recommendations to support their critical work by expanding tax credits and training for caregivers and improving access to virtual care.
August 27, 2020
Recommendations for Canada’s long-term recovery plan - open letterThis joint letter to the prime minister outlines a series of recommendations to address gaps exposed by the COVID-19 pandemic, in areas such as virtual care, support for older adults, Canada’s National Anti-Racism Strategy, primary care, pharmacare and mental health resources for health care professionals.
August 13, 2020
Taking action on drug shortages during COVID-19 - open letterThis joint letter to the prime minister puts forward a strategy to address drug shortages, including stockpiling critical medications, identifying manufacturers to specialize in producing critical drugs, and ensuring greater transparency and communications among governments and the health sector.
August 7, 2020
CMA pre-budget submissionThis submission proposes recommendations to expand public health capacity and primary care access; scaling up virtual care and addressing inequities in access to digital health services; ensuring better care is secured for seniors; and mitigating the risks and financial burdens experienced by physicians and front-line health care workers.
June 5, 2020
Submission in Response to the Consultation on the Canada Emergency Wage Subsidy: Keeping Medical Clinic Employees on the PayrollSubmitted to Finance Canada, this submission provides a briefing on physician practices and the need to access the Canada Emergency Wage Subsidy, an overview of the technical and administrative factors impeding access, and proposed federal actions to help resolve these barriers.
June 2, 2020
Federal measures to recognize the significant contributions of Canada’s front-line health care workers during the COVID-19 pandemicThe CMA and a coalition of health care associations recommend the federal government implement a series of measures for front-line health care workers, including an income tax deduction in recognition of their efforts, an emergency accommodation tax deduction to support physical distancing and additional child-care relief.
June 1, 2020
Improving Long-term Care for People in CanadaCMA signs joint letter to the minister of health endorsing the Canadian Nurses Association’s recommendations to the federal government for improving long-term care for Canadians.
May 28, 2020
Responding to the COVID-19 pandemicIn this submission to the finance minister, the CMA recommends the federal government expand eligibility for existing COVID-19 economic relief programs and implements new measures to address the unique financial challenges of front-line health workers during the pandemic.
March 23, 2020
Protecting and supporting Canada’s health care providers during COVID-19Writing to the prime minister and Saskatchewan premier, the CMA and several other health associations urge governments to make personal protective equipment readily available, put emergency funding and support programs in place for care providers, and share adequate, timely, evidence-based information on the pandemic.
March 16, 2020
CMA recommendations for emergency federal measures to care for and protect Canadians during the COVID-19 pandemicIn this submission to the finance minister, the CMA recommends the federal government implement six priority measures to support the domestic response to the COVID-19 pandemic
February 25, 2020
2020 pre-budget submission to the House of Commons Standing CommitteeThis submission proposes a one-time fund of $1.2 billion over four years to help establish models of primary care in each province and territory
February 5, 2020
CMA submission: Climate governance in QuebecIn this submission to the Quebec Committee on Transportation and the Environment on Bill 44, the CMA recommends a health representative be part of the minister’s advisory committee, and a portion of the Green Fund be dedicated to greening health systems
January 20, 2020
CMA response: Health Canada consultation on proposed vaping products promotion regulationsThe CMA recommends vaping ads be banned in all public spaces, publications and broadcast media, with no exceptions and for health warnings on packaging similar to tobacco. It also calls for lower limits on nicotine concentrations and banning flavours
January 15, 2020
CMA submission: Senior care and prevention – For a healthier Quebec: Pre-budget submission for the 2020–2021 Quebec government budgetThis submission to the National Assembly of Quebec proposes recommendations to support seniors and their caregivers, heavily…
September 5, 2019
CMA response: Health Canada consultation on vaping products labelling and packaging regulationsThe CMA supports tighter restrictions on nicotine levels in vaping products and health warnings on packaging similar to those used for tobacco products. It also recommends all vaping substances and ingredients be labelled
September 3, 2019
CMA response: Health Canada consultation on potential market for cannabis health productsRecommendation by CMA that all cannabis health products that make health claims, including those with CBD, be reviewed thoroughly for efficacy, safety and quality. CMA also recommends strict packaging requirements and childproof containers to ensure consumer safety
August 2, 2019
CMA submission: Acting on Today’s and Tomorrow’s Health Care NeedsThe CMA’s pre-budget submission to the House of Commons Standing Committee on Finance provides recommendations to improve access to primary care, better prepare for and mitigate the health impacts of a changing climate, and more
May 24, 2019
CMA response: Health Canada consultation on reducing youth access and appeal of vaping productsThe CMA reiterates its calls for all vaping ads to be banned in public spaces, for regulations restricting the flavours and nicotine levels in vaping products, and for Health Canada to develop a youth-focused communication campaign about the health impacts of vaping
March 22, 2019
CMA Response: Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco productsThe CMA calls for vaping to be banned in public spaces, to prevent marketing to youth, and for health warnings to be placed on all vaping products
February 20, 2019
CMA response: Health Canada consultation on edible cannabis, extracts and topicalsTo ensure safety, the CMA supports restrictions on product potency and the use of additives, and the prohibition of edibles in appealing flavours and shapes. It also calls for plain, childproof packaging, with clear content, potency and health warnings
December 14, 2018
CMA Response: Health Canada’s consultation on new health-related labelling for tobacco productsThe CMA reiterates its long-standing support for tobacco products being sold in standardized packages, with health warning labelling, and supports similar labelling on individual cigarettes
December 4, 2018
CMA response: Health Canada consultation on Canadian drugs and substances strategyThe CMA supports a public health approach to substance use issues, and a comprehensive national strategy to address the harms associated with psychoactive drugs
October 2, 2018
CMA submission: Implementation of national pharmacareIn this submission to the Advisory Council on the Implementation of National Pharmacare, the CMA urges the federal government to explore universal coverage for 125 essential medicines
September 6, 2018
CMA brief on plain packaging: Health Canada consultationThe CMA supports Health Canada’s proposal to enforce standardized packaging for tobacco products with specific recommendations for packaging appearance and dimensions
August 14, 2018
CMA response: Consultation on Regulatory Amendments regarding TramadolTo protect Canadians’ health and safety, the CMA advises tramadol be placed on Schedule 1 of the Controlled Drugs and Substances Act
July 18, 2018
CMA response: Consultation on Restriction of Marketing and Advertising of OpioidsThe CMA supports Health Canada’s efforts to restrict the ability of drug manufacturers to advertise opioids to health care practitioners
June 6, 2018
Canada's Food GuideThe CMA calls for a modern, practical Canada Food Guide based on sound nutritional evidence in a submission to the House of Commons Standing Committee on Health
April 23, 2018
CMA letter to Health CanadaThe CMA issues a letter to Health Canada calling for front-of-packaging labelling on food and beverages
April 18, 2018
Bill C-45: CMA submission to the Senate Standing Committee, Social Affairs, Science & TechnologyTo support deliberations of the House of Commons Standing Committee on Health, the CMA submits a brief on Bill C-45, the Cannabis Act, promoting a broad legal-regulatory framework
March 8, 2018
Meeting the Demographic Challenge: Investments in Seniors CareThe CMA’s pre-budget submission to the House of Commons Standing Committee on Finance proposes that the federal government fund a share of the health care costs associated with Canada’s aging population
February 15, 2018
CMA recommendations to the House of Commons for Bill S-5The CMA submits recommendations to the House of Commons regarding Bill S-5 to support population health, protect youth and restrict the promotion of vaping products
February 13, 2018
Federal monitoring of medical assistance in dying regulationsThe CMA provides input to Health Canada on its proposed regulations for the federal monitoring of medical assistance in dying in Canada, supporting the intent and highlighting areas for consideration, including the need for clear definitions and reasons for ineligibility
January 19, 2018
Proposed Approach to the Regulation of CannabisThe CMA makes a submission to Health Canada on the proposed cannabis regulations — focusing on prevention, harm reduction, and other measures consistent with a public health approach
December 17, 2017
Excise Duty Framework for Cannabis ProductsThe CMA weighs in on the federal government’s proposed excise duty framework for cannabis products, highlighting the importance of a public health approach to legalization and recommending tax revenue from cannabis be earmarked to fund prevention, education and treatment initiatives
November 7, 2017
CMA submission on Non-Prescription Availability of Low-Dose Codeine ProductsIn the interest of promoting public health and patient safety, the CMA endorses the requirement that all products containing low-dose codeine be sold by prescription only
October 26, 2017
Advancing Inclusion and Quality of Life for SeniorsThe CMA recommends ways to improve seniors’ quality of life as part of a study by the House of Commons Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities
September 21, 2017
CMA submission: Social Equity and Increasing ProductivityThe CMA’s 2018 pre-budget submission to the House of Commons Standing Committee of Finance includes recommendations to improve health care system productivity and effectiveness for Canada’s growing seniors population
August 18, 2017
Bill C-45: CMA submission to the House of Commons Standing Committee on HealthThe CMA’s submission to the House of Commons Standing Committee on Health recommends the legalization age for cannabis be changed to 21 and that the government undertake a multi-facted public health strategy to minimize the health risks associated with cannabis consumption
June 28, 2017
CMA response: Patented Medicines Regulations ConsultationsThe CMA responds to Health Canada consultations on patented medicines regulations, calling for revisions to bring transparency and clarity to price setting of patented medicines
June 28, 2017
CMA response: Patented Medicines Regulations ConsultationsThe CMA calls for revisions to Patented Medicines Prices Review Board regulations to ensure: a) transparency and clarity in setting patented medicine prices; b) the lowest possible costs; and c) continued access to a wide variety of pharmaceutical products
June 14, 2017
CMA support for Bill S-228The CMA’s support for Bill S-228: An Act to amend the Food and Drugs Act (prohibiting food and beverage marketing directed at children)
May 15, 2017
Federal Monitoring and Reporting Regime for MAIDIn a submission to Health Canada, the CMA recommends features of a federal monitoring and reporting regime for medical assistance in dying, including privacy protection and a clear definition of what constitutes a request
April 7, 2017
CMA recommendations to the Senate Standing Committee on Social Affairs, Science and Technology for Bill S-5The CMA submits recommendations to the Senate Standing Committee on Social Affairs, Science and Technology regarding Bill S-5 to support population health, protect youth and restrict the promotion of vaping products
April 6, 2017
CMA submission on the study of Bill C-37: An Act to amend the Controlled Drugs and Substances ActThe CMA makes recommendations to the Senate Committee on Legal and Constitutional Affairs about Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts
April 5, 2017
Consultation on the renewal of Federal Tobacco Control StrategyInformation and the CMA’s position on smoking cessation submitted as part of Health Canada’s consultation on the renewal of the Federal Tobacco Control Strategy
February 28, 2017
CMA recommendations for Effective Poverty Reduction StrategiesThe CMA recommends poverty reduction strategies in support of a study by the House of Commons Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities
January 10, 2017
CMA response to Health Canada's Proposed Order Amending the Schedule to the Tobacco ActThe CMA registers its support for Health Canada’s Proposed Order Amending the Schedule to the Tobacco Act (Menthol) prohibiting menthol in cigarettes, blunt wraps and cigars
October 18, 2016
CMA statement to the House of Commons Standing Committee on HealthDr. Jeff Blackmer, CMA Vice-president of Medical Professionalism, speaks before the House of Commons Standing Committee on Health about Canada’s escalating public health crisis related to problematic opioid and fentanyl use
August 29, 2016
Legalization, Regulation and Restriction of Access to MarijuanaIn a submission to the Government of Canada Task Force on Marijuana Legalization and Regulation, the CMA calls for a broad public health policy approach for cannabis legalization and regulation in Canada
August 12, 2016
Health Canada’s Consultation on “Plain and Standardized Packaging”The CMA recommends guidelines for regulating the appearance, shape and size of tobacco packaging and products in response to Health Canada’s consultation on the matter
June 1, 2016
National Pharmacare in Canada: Getting There from HereIn a submission to the House of Commons Standing Committee on Health, the CMA calls for federal leadership and financial contribution to support a national pharmacare program on par with Canada’s Medicare program
June 1, 2016
National Pharmacare in Canada: Getting There from HereThe CMA submits background to support a federal study on the development of a national pharmacare program, underscoring the need for federal government leadership and financial support
May 12, 2016
CMA submission: Reducing barriers to physician mobility and for a more uniformed health care system in CanadaThe CMA puts forward a series of recommendations for the federal government to help reduce barriers to mobility of physicians and enhance uniform access to care
March 19, 2016
CMA response: Consultation on the Prescription Drug List: NaloxoneIn response to Health Canada’s consultation on the prescription drug list, the CMA advocates for increased access to naloxone for emergency treatment of opioid overdose outside hospitals
January 20, 2016
Regulatory Framework for the Mandatory Reporting of Adverse Drug Reactions and Medical Device Incidents by Provincial and Territorial Healthcare InstitutionsThe CMA recommends improvements to Canada’s adverse drug reactions reporting system in response to a Health Canada consultation
October 19, 2015
CMA formal submission to the Federal External Panel on assisted dyingIn its submission to the Federal External Panel on Options for a Legislative Response to Carter vs. Canada, the CMA puts forward its position on the forthcoming legislative and regulatory framework to govern assisted dying in Canada, calling for a national, pan-Canadian approach
June 8, 2015
CMA response: Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)The CMA calls for enhancements and revised guidance in response to Health Canada’s public consultation on the Guide to New Authorities under Bill C-17 Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law)
June 2, 2015
Obesity in Canada: Causes, Consequences and the Way ForwardIn a submission to the Senate Standing Committee on Social Affairs, Science and Technology, the CMA shares the physician perspective on the causes and consequences of obesity in Canada and recommends ways to help Canadians make healthy food choices
May 14, 2015
CMA submission to the Senate Standing Committee on Legal and Constitutional Affairs on Bill C-2: An Act to Amend the Controlled Drugs and Substances ActThe CMA presents its concerns with Bill C-2 before the Senate Standing Committee on Legal and Constitutional Affairs, including that the new legislation could make it harder to create new supervised consumption sites
March 25, 2015
Accessibility: the solution lies in cooperationA joint brief from the CMA and the Québec Medical Association on improving access to health care in the province of Quebec
December 8, 2014
CMA submission to Advisory Panel on Healthcare InnovationA CMA submission to the Advisory Panel on Healthcare Innovation highlights five innovations to support Canada’s growing seniors population, including supportive living models that use technology to help seniors stay in their homes
November 27, 2014
CMA submission to the House of Commons Study on E-CigarettesInformation submitted on the current regulatory status and health implications of e-cigarettes, along with recommendations to support the House of Commons Health Committee study on e-cigarettes
November 10, 2014
CMA submission to Health CanadaThe CMA supports Health Canada’s proposed order to amend the schedule to the Tobacco Act to prohibit the use of certain flavoring additives in cigars — and recommends the ban be extended to menthol in all tobacco products
October 28, 2014
CMA submission to the House of Commons Standing Committee on Public Safety and National Security on Bill C-2: An Act to Amend the Controlled Drugs and Substances ActConcerns about the potential of Bill C-2 impede the creation of new supervised consumption sites feature in the CMA’s submission to the House of Commons Standing Committee on Public Safety and National Security
August 26, 2014
CMA response on Tamper Resistance under the Controlled Drugs and Substances ActThe CMA advocates for regulations requiring products containing certain controlled substances to be tamper-resistant as a condition for sale in Canada
August 6, 2014
Improving Seniors Care in an Era of SurplusThe CMA’s 2014-2015 pre-budget consultation submission calls on the federal government to invest strategically in long-term health care sustainability due to Canada’s aging population
July 27, 2014
Factum of the Intervener, the Canadian Medical AssociationThe CMA submits an affidavit and factum on medical assistance in dying to the Supreme Court of Canada to support the Court’s judgment in Carter v. Canada, which challenged the provision in the Criminal Code prohibiting assisted suicide
July 11, 2014
Proposed amendments to the Marijuana for Medical Purposes RegulationsThe CMA responds to Health Canada’s proposed regulatory amendments governing medicinal cannabis, raising concerns about the scarcity of evidence for using cannabis as medical therapy as well as other objections to the existing regulatory framework
June 2, 2014
CMA submission: Bill C-422 An Act respecting a National Lyme Disease StrategyIn this submission, the CMA recognizes the importance of reporting and monitoring infectious diseases in Canada that emerge in relation to global climate change
May 27, 2014
The Health Risks and Harms Associated with the Use of MarijuanaIn a submission to the House of Commons Standing Committee on Health, the CMA outlines health risks and harms associated with cannabis use to support the committee’s study on the topic and advocates for a public health approach to psychoactive substance use
May 15, 2014
Higher rate now: Why excise tax on tobacco is long overdue for an increaseThe CMA calls for an increase in the excise tax on tobacco in a submission to the Standing Senate Committee on Banking, Trade and Commerce, citing research that suggests price increases reduce the number of cigarettes smoked and smoking prevalence rates
March 26, 2014
CMA submission on the Senate study on prescription pharmaceuticalsIn support of the Senate Committee on Social Affairs, Science and Technology study on prescription pharmaceuticals in Canada, the CMA recommends ways for the federal government to address the unintended consequences of prescription pharmaceuticals and support public health, quality care and patient safety
March 17, 2014
CMA submission on the Review of Controlled Drugs and Substances ActThe CMA’s response to Health Canada’s consultation on the Controlled Drugs and Substances Act and its regulations recommends new measures and mechanisms for improving public health and safety, including enhancements to controlled substance approval, labelling and safety monitoring
November 27, 2013
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in CanadaThe CMA supports the House of Commons Standing Committee on Health study on the government’s role in addressing prescription drug abuse in Canada with background on the issue and recommendations for tackling the issue, including national strategies for reducing misuse and promoting optimal prescribing
November 6, 2013
Healthier Generations for a Prosperous Economy: CMA 2013-2014 pre-budget consultation submissionIn a pre-budget consultation submission to the Standing Committee on Finance, the CMA recommends federal investment in the social determinants of health, a seniors care strategy and other priorities
April 25, 2013
CMA submission: Motion 315 (Income Inequality)The CMA recommends measures to combat income inequality in Canada as part of submission to the House of Commons Standing Committee on Finance
February 28, 2013
CMA response: Health Canada’s Medical Marijuana Regulatory ProposalA CMA submission to Health Canada’s Office of Controlled Substances calls attention to the lack of evidence-based information about the drug’s use as medical therapy and recommends support for scientific research, knowledge translation and other activities to meet physicians’ information needs
November 1, 2012
A More Robust Economy through a Healthier Population: CMA 2012-2013 pre-budget submissionThe CMA’s pre-budget submission recommends ways the federal government can help transform Canada’s health care system and improve the health of Canadians, including recognizing the implications of the social determinants of health on system demand
May 31, 2012
CMA submission to the House of Commons Standing Committee on Finance Study of Bill C-38CMA President Dr. Jeffrey Turnbull presents the physician perspective on why policy-makers need to pay greater attention to the social determinants of health in an address to the House of Commons Standing Committee on Finance
May 9, 2012
CMA submission: A Doctor for Every Canadian − Better Planning for Canada's Health Human ResourcesThe CMA underscores the need for a pan-Canadian approach to ensure adequate health human resources, in support of a sustainable health care system
October 17, 2011